Monday, February 27, 2012 7:59:11 PM
You're right, what they are using has the ability for time, so either it really is coming out at midnight, or whomever coded the site didn't bother picking a time:
var AnticipateDay = new Date();
AnticipateDay = new Date('03/01/2012 00:00');
jQuery('#anticipate-timer').countdown({until: AnticipateDay,layout: '<span class="timer"><strong>{dn}</strong> {dl}</span><span class="timer"><strong>{hn}</strong> {hl}</span><span class="timer"><strong>{mn}</strong> {ml}</span><span class="timer"><strong>{sn}</strong> {sl}</span>'});
var AnticipateDay = new Date();
AnticipateDay = new Date('03/01/2012 00:00');
jQuery('#anticipate-timer').countdown({until: AnticipateDay,layout: '<span class="timer"><strong>{dn}</strong> {dl}</span><span class="timer"><strong>{hn}</strong> {hl}</span><span class="timer"><strong>{mn}</strong> {ml}</span><span class="timer"><strong>{sn}</strong> {sl}</span>'});
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
